课题基金 / 基金详情

项目摘要

项目成果

John Bernard Buse的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 本申请是作为对NOT-TR-20-014的回应而提交的,作为家长奖的补充 UL 1 TR 002489,北卡罗来纳州转化和临床科学研究所(NC TraCS)。这个CTSA 行政补充将为NC增加一个专门的质量保证/质量控制职位 TraCS监管知识和支持计划,以执行CTSA相关的质量审查 向NCATS提交,向eRA人类受试者系统提交,以及管理 事先批准程序。本补编将处理以下具体目标: 目标1 -设立一个专门的职位,监督和管理内部流程,以便事先批准 要求NCATS。 目标2 -执行全面评价战略,以指导决策并确保 流程的持续改进。
英文摘要
Project summary This application is submitted in response to NOT-TR-20-014 as a supplement to Parent Award UL1TR002489, the North Carolina Translational and Clinical Sciences Institute (NC TraCS). This CTSA Administrative Supplement will add a dedicated quality assurance/quality control position to the NC TraCS Regulatory Knowledge and Support Program to perform quality reviews of CTSA-related submissions to NCATS, submissions to the eRA Human Subjects System, and management of the overall prior approval process. The following specific aims will be addressed by this supplement: Aim 1 – Create a dedicated position to oversee and manage internal processes for prior approval requests to NCATS. Aim 2 – Implement a comprehensive evaluation strategy to guide decision-making and ensure continuous improvement in processes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
North Carolina Translational and Clinical Sciences Institute (NC TraCS)
  • 批准号:
    10621596
  • 项目类别:
  • 资助金额:
    $1004.21万
  • 财政年份:
    2023
  • 负责人:
    John Bernard Buse
  • 依托单位:
CTSA Diversity Supplement - Vielot - Effectiveness of Recombinant Herpes Zoster Vaccine in Older U.S. Adults
CAMP FHIR: Lightweight, Open-Source FHIR Conversion Software to Support EHR Data Harmonization and Research
ICEES+ COVID-19 Open Infrastructure to Democratize and Accelerate Cross-Institutional Clinical Data Sharing and Research
海外基金